Low Testosterone Symptoms: When Labs Matter, and When They Don't
The symptoms attributed to low testosterone are shared by half a dozen other conditions. Testing matters, but so does what you do with the result - and a number on its own is not a diagnosis.

Key takeaways
- The symptoms attributed to low testosterone - fatigue, low mood, reduced libido, poor concentration - are non-specific and overlap with sleep apnea, thyroid disease, depression, alcohol use and simple sleep deprivation.
- A diagnosis requires both symptoms and consistently low testosterone. Neither alone is sufficient.
- Testosterone should be measured in the morning, fasting, and on two separate occasions. Roughly 30% of men with a low first result are normal on repeat.
- When low testosterone is attributable to excess weight with no other cause identified, weight loss is generally considered first-line rather than testosterone therapy.
- Some men who ask for testosterone therapy should not receive it, and saying so is part of good care.
I trained and practiced in emergency medicine before opening this clinic. One thing that environment teaches quickly is that a number on a screen is not a diagnosis. A patient with an abnormal value who feels fine and a patient with a normal value who is deteriorating are both common, and treating the number instead of the person is how mistakes happen.
That principle carries directly into hormone care, where it is frequently ignored.
The symptoms are real. They are also non-specific.
Men who suspect low testosterone usually describe some combination of the following: persistent fatigue that sleep does not fix, reduced libido, difficulty building or maintaining muscle, increasing abdominal fat, low mood, irritability, and trouble concentrating.
Those symptoms are real and they are worth investigating. But every one of them appears on the symptom list for several other conditions:
- Obstructive sleep apnea, which is underdiagnosed and which independently suppresses testosterone
- Thyroid dysfunction, particularly hypothyroidism
- Depression, which shares nearly the entire symptom list
- Iron deficiency or anemia
- Poorly controlled blood sugar or insulin resistance
- Chronic sleep restriction, which lowers testosterone measurably within a week
- Alcohol intake above modest levels
- Certain medications, including opioids, some antidepressants and glucocorticoids
If a clinic runs one testosterone level, finds it below a threshold, and starts treatment, it has not ruled out any of the above. It has found a number that correlates with how the patient feels and stopped looking.
What proper testing actually involves
Testosterone measurement is more fragile than most people expect.
Levels follow a daily rhythm and are highest in the morning. Food and glucose intake suppress them. Acute illness lowers them. Day-to-day variation within the same person is large enough that a single measurement is not adequate for diagnosis.
For those reasons, professional guidelines are consistent on the method: measure total testosterone in the morning, in a fasting state, using an accurate assay, and confirm any low result by repeating it on a separate morning.
The reason for repeating is not bureaucratic. Approximately 30% of men whose first testosterone measurement falls in the hypogonadal range have a normal level on repeat testing. If you treat on a single draw, roughly one in three men you start on therapy did not have consistently low testosterone in the first place.
Assay quality matters too. Testosterone assays vary meaningfully between laboratories, and the Endocrine Society specifically recommends assays certified through the CDC's Hormone Standardization program because non-standardized assays can produce inconsistent results from the same sample.
Where the threshold sits, and why it is not a bright line
The American Urological Association uses total testosterone below 300 ng/dL as the threshold defining low testosterone. Other bodies have used values ranging from roughly 230 to 350 ng/dL.
That spread should tell you something. There is no biological cliff at 300. A man at 310 with significant symptoms and a man at 290 with none are not meaningfully different physiologically, and treating one while dismissing the other because of a threshold is exactly the error I am describing.
Where total testosterone sits near the lower limit, or where a condition alters sex hormone-binding globulin - obesity and thyroid disease both do - free testosterone becomes the more informative measurement.
The finding most clinics do not mention
When low testosterone is attributable to excess weight, with no other cause identified, current Endocrine Society guidance holds that weight loss should generally be considered first-line treatment rather than testosterone therapy.
This matters commercially and clinically, and it is worth being direct about the tension: a clinic that sells testosterone therapy has an obvious incentive not to lead with this. Adipose tissue converts testosterone to estradiol and contributes to suppression, and meaningful weight loss frequently raises testosterone without any hormone being prescribed.
For a subset of men who arrive asking for testosterone, the correct answer is a metabolic evaluation and a weight management plan - sometimes both, in sequence. That is a less profitable answer. It is also the right one.
What the safety evidence currently shows
The TRAVERSE trial, which enrolled more than 5,200 middle-aged and older men with hypogonadism, was designed to answer the cardiovascular safety question that had hung over testosterone therapy for years. Over one to four years it found no meaningful increase in heart attack or stroke.
That is genuinely reassuring, and it resolved the largest open question in the field.
It did not resolve everything. The same trial found a higher rate of pulmonary embolism in treated men, and a prespecified substudy found that testosterone did not reduce fracture risk - clinical fractures over three years occurred in roughly 4% of treated men compared with 2.8% on placebo. Long-term safety, including any effect on prostate cancer risk, remains unestablished, in part because prostate cancer develops slowly and the trials have not run long enough to answer it.
None of that makes testosterone therapy unsafe for appropriately selected men. It does mean the conversation before starting should be a real one, and that monitoring afterward is not optional.
Who should not start testosterone therapy
Testosterone therapy suppresses sperm production. Men who are trying to conceive, or who plan to in the near term, should not start it without a fertility-preserving strategy discussed in advance. This is the single most common thing men are not told before starting elsewhere, and it is reversible in most but not all cases.
Other situations that warrant caution or exclusion include untreated obstructive sleep apnea, an elevated hematocrit, active prostate cancer or an unevaluated prostate abnormality, an elevated PSA that has not been worked up, recent cardiovascular events, and uncontrolled heart failure.
Enclomiphene is sometimes used as an alternative that raises testosterone without suppressing fertility. It is not FDA-approved for this indication and its use here is off-label - a fact that should be stated plainly to any patient considering it, along with what off-label means and does not mean.
What we do differently
Two morning fasting draws before any diagnosis. A full evaluation for the other causes on the list above, not just a testosterone panel. An explicit conversation about fertility before anything is prescribed. Ongoing monitoring of hematocrit, PSA where appropriate, and symptom response rather than chasing a target number.
And a willingness to tell a man that his testosterone is not the problem. That happens, and when it does, saying so is the service.
Frequently asked questions
What is a normal testosterone level for my age?
Reference ranges vary by laboratory and assay, which is part of the problem. The American Urological Association uses 300 ng/dL as the threshold below which testosterone is considered low, though other organizations use values from roughly 230 to 350. More important than the number is whether it is consistently low across two morning fasting measurements and whether it is accompanied by symptoms.
Why do I need two tests instead of one?
Because roughly 30% of men with a low first result have a normal level when retested. Testosterone varies through the day, drops after eating, and fluctuates day to day. A single measurement is not enough to diagnose anything.
Could my symptoms be something other than low testosterone?
Frequently, yes. Sleep apnea, thyroid disease, depression, anemia, insulin resistance, chronic sleep loss, alcohol and several common medications all produce the same symptom picture. A proper evaluation looks for these rather than assuming.
Will testosterone therapy affect my fertility?
Yes. Testosterone therapy suppresses sperm production and can reduce fertility significantly. If you are planning to have children, tell your physician before starting, so that alternatives or fertility-preserving approaches can be discussed.
Is testosterone therapy safe for the heart?
The TRAVERSE trial, in more than 5,200 men, found no meaningful increase in heart attack or stroke over one to four years. The same trial found more pulmonary embolism among treated men, and long-term effects including prostate cancer risk remain unestablished. Safety depends substantially on appropriate selection and ongoing monitoring.
If I lose weight, will my testosterone go up?
Often. Excess weight suppresses testosterone through several mechanisms, and weight loss frequently raises it without hormone therapy. Where low testosterone appears attributable to weight with no other cause found, current guidance treats weight loss as first-line.
Do you take insurance for testosterone therapy?
Aevum does not bill insurance. Non-member TRT monotherapy is $250 per month and comprehensive therapy is $300 per month, billed monthly. Members receive tiered discounts.
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. doi:10.1210/jc.2018-00229
- Lincoff AM, Bhasin S, Flevaris P, et al; TRAVERSE Study Investigators. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. doi:10.1056/NEJMoa2215025
- American Urological Association. Testosterone Deficiency Guideline. auanet.org
- Endocrine Society. Statement on testosterone replacement therapy. 2026.
Medically reviewed
Xinwei Liu
MD
October 15, 2026
October 15, 2026
This article is for general education and is not medical advice. Individual results vary. Speak with a licensed clinician about your own situation.
Next step
Lab-guided care starts with a conversation, not a product.
Learn about testosterone therapy in HoustonBook a ConsultationAevum Restorative Wellness
1224 Houston Avenue, Suite 101, Houston, TX 77007
713-280-1551
care@aevumrestorative.com
Monday to Friday, 10am to 7pm; Saturday and Sunday, 9am to 5pm





